Resources Contact Us Home
A.sub.3 adenosine receptor agonists

Image Number 13 for United States Patent #5688774.

The present invention provides A.sub.3 selective agonists, particularly, adenine compounds having selected substituents at the 2, 6, and 9 positions, and related substituted compounds, particularly those containing substituents on the benzyl and/or uronamide groups, as well as pharmaceutical compositions containing such compounds. The present invention also provides a method of selectively activating an A.sub.3 adenosine receptor in a mammal, which method comprises acutely or chronically administering to a mammal in need of selective activation of its A.sub.3 adenosine receptor a therapeutically or prophylactically effective amount of a compound which binds with the A.sub.3 receptor so as to stimulate an A.sub.3 receptor-dependent response.

  Recently Added Patents
Patterned MR device with controlled shape anisotropy
Active and progressive targeted advertising
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
Analog to digital converter with increased sub-range resolution
Resist underlayer film forming composition for lithography, containing aromatic fused ring-containing resin
Integrated disk driving module including a stepping motor integrally formed with a base unit
Phase locking loop
  Randomly Featured Patents
Exercise apparatus
Paclitaxel enhancer compounds
Multiple spindle drilling machine for wide flange beams
Biodegradable nonwoven fabrics
Method, system, and medium for winning bid evaluation in an auction
Device for detecting shortage of products in a package
Night vision glasses
Coupling construction between an extended-nip roll and a backup roll
Multiplier with built-in accumulator